|1.||Wu, Gusheng: 5 articles (09/2011 - 11/2005)|
|2.||Ledeen, Robert W: 4 articles (09/2011 - 11/2005)|
|3.||Lu, Zi-Hua: 2 articles (09/2011 - 11/2005)|
|4.||Amin, Ruchi: 1 article (09/2011)|
|5.||Kulkarni, Neil: 1 article (09/2011)|
|6.||Ledeen, Robert: 1 article (11/2007)|
|7.||Xie, Xin: 1 article (11/2005)|
|8.||Wang, Jianfeng: 1 article (11/2005)|
|9.||Meyenhofer, Markus F: 1 article (11/2005)|
|10.||Wang, Yvette: 1 article (11/2005)|
04/01/2006 - "As further indication of Ca2+ dysregulation, the mutant mice were highly susceptible to kainite-induced seizures which were attenuated by LIGA-20. "
03/01/2006 - "The seizures were effectively attenuated by LIGA20 in parallel with the ability of this agent to enter brain cells, insert into the NE, and potentiate Na(+)/Ca(2+) exchange activity in the nucleus. "
11/23/2005 - "Seizure activity in the KO mouse was only moderately diminished by intraperitoneal injection of GM1 ganglioside, whereas LIGA 20, a semisynthetic analog of GM1, substantially reduced both seizure severity and cell damage. "
11/01/2007 - "Further indication came from a study of the mutant mice, which were highly susceptible to kainate-induced seizures and could be rescued by LIGA-20. "
11/23/2005 - "Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA 20, a membrane-permeant analog of GM1."
|2.||Parkinsonian Disorders (Parkinsonism)
|1.||Kainic Acid (Kainate)